HRP20041152B1 - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
HRP20041152B1
HRP20041152B1 HR20041152A HRP20041152A HRP20041152B1 HR P20041152 B1 HRP20041152 B1 HR P20041152B1 HR 20041152 A HR20041152 A HR 20041152A HR P20041152 A HRP20041152 A HR P20041152A HR P20041152 B1 HRP20041152 B1 HR P20041152B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical formulations
decomposes
mouth
seconds
dosage form
Prior art date
Application number
HR20041152A
Other languages
Croatian (hr)
Inventor
Anders Lars
Lindner Hans
Jørgen Wittendorff Jansen
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210397.6A external-priority patent/GB0210397D0/en
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of HRP20041152A2 publication Critical patent/HRP20041152A2/en
Publication of HRP20041152B1 publication Critical patent/HRP20041152B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Orodisperzibilni farmaceutski oblik doziranja desmopresin acetata, naznačen time, da se razgrađuje u ustima u roku od 10 sekundi. Patent sadrži još 16 patentnih zahtjeva.Orodispersible pharmaceutical dosage form of desmopressin acetate, which decomposes in the mouth within 10 seconds. The patent contains 16 more claims.

HR20041152A 2002-05-07 2004-12-03 Pharmaceutical formulations HRP20041152B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0210397.6A GB0210397D0 (en) 2002-05-07 2002-05-07 Pharmaceutical formulations
PCT/IB2002/004036 WO2003094885A1 (en) 2002-05-07 2002-09-20 Sublingual pharmaceutical formulation of desmopressin
PCT/IB2003/002368 WO2003094886A2 (en) 2002-05-07 2003-05-07 Desmopressin in an orodispersible dosage form

Publications (2)

Publication Number Publication Date
HRP20041152A2 HRP20041152A2 (en) 2005-04-30
HRP20041152B1 true HRP20041152B1 (en) 2008-01-31

Family

ID=29422105

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20041152A HRP20041152B1 (en) 2002-05-07 2004-12-03 Pharmaceutical formulations

Country Status (10)

Country Link
JP (1) JP2006502972A (en)
AU (1) AU2003233118B8 (en)
BR (1) BR0309819A (en)
CA (1) CA2484724C (en)
DE (2) DE60307082D1 (en)
HR (1) HRP20041152B1 (en)
NO (1) NO335167B1 (en)
NZ (1) NZ535861A (en)
PT (1) PT1501534E (en)
WO (1) WO2003094886A2 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
JP4523265B2 (en) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 Orally disintegrating preparations for the treatment of urination disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DK1500390T3 (en) 2003-07-25 2005-09-19 Ferring Bv Pharmaceutical composition as solid dosage form and method of preparation thereof
EP2322194A2 (en) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (en) * 2003-11-13 2006-11-01 Ferring B.V. BLISTER PACKAGE AND SOLID PHARMACEUTICAL FORM FOR IT.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
ES2254858T3 (en) * 2003-12-29 2006-06-16 Ferring B.V. METHOD FOR PREPARING A SOLID PHARMACEUTICAL FORM OF DESMOPRESIN.
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
GB0406048D0 (en) * 2004-03-18 2004-04-21 Ardana Bioscience Ltd Drug formulations
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
SE528446C2 (en) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Pharmaceutical composition comprising desmopressin, silica and starch
CA2584456C (en) * 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
WO2009015037A2 (en) 2007-07-21 2009-01-29 Albany Molecular Research, Inc. 5-pyridinone substituted indazoles
CA2988753A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US20090324569A1 (en) 2007-11-21 2009-12-31 Decode Genetics Ehf Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
MX2010007430A (en) 2008-01-11 2010-12-21 Albany Molecular Res Inc (1-azinone) -substituted pyridoindoles as mch antagonists.
EP2296686B2 (en) * 2008-05-21 2017-11-01 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
EP2389383B1 (en) 2009-01-26 2019-04-24 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
TWI468157B (en) * 2009-04-29 2015-01-11 Intervet Int Bv Process to form a tablet, system for performing this process and package comprising the tablet
TWI471127B (en) 2009-04-29 2015-02-01 Intervet Int Bv A process for preparing an orally disintegrating tablet for human use, an orally disintegrating tablet thus obtained and a package containing the orally disintegrating tablet
CN108295241A (en) 2009-06-18 2018-07-20 宁静制药公司 The desmopressin administration of safety
BR112012000788A2 (en) 2009-07-14 2016-02-23 Albany Molecular Res Inc 5-ht3 receptor modulators, methods for preparing and using them
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
MX341200B (en) 2010-03-29 2016-08-11 Ferring Bv A fast dissolving pharmaceutical composition.
JO3112B1 (en) * 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
MX347101B (en) * 2010-10-08 2017-04-12 Scherer Technologies Llc R P Oral vaccine fast-dissolving dosage form using starch.
JP2011116764A (en) * 2011-02-08 2011-06-16 Fine Seymour H Medical composition containing low dose desmopressin
AU2012307530B2 (en) 2011-09-16 2016-12-08 Ferring B.V. A fast dissolving pharmaceutical composition
JP5928159B2 (en) * 2012-05-28 2016-06-01 ニプロ株式会社 Pharmaceutical composition
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release
CN103993061B (en) * 2014-05-20 2018-03-23 海南美合泰生物科技有限公司 A kind of production method of Isin glue collagen
KR20150144209A (en) * 2014-06-16 2015-12-24 훼링 비.브이. Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof
JP6341777B2 (en) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー Pharmaceutical composition containing low dose desmopressin
AU2018208531A1 (en) 2017-01-11 2019-06-13 Ferring B.V. A fast disintegrating pharmaceutical composition
DE102017104472A1 (en) * 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Orodispersible tablet containing burlulipase and pharmaceutical composition prepared therefrom
EP3768267A4 (en) 2018-03-20 2022-04-20 Icahn School of Medicine at Mount Sinai Kinase inhibitor compounds and compositions and methods of use
CA3124700A1 (en) 2018-12-31 2020-07-09 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
EP0517211A1 (en) * 1991-06-07 1992-12-09 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide containing pharmaceutical composition
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
WO2000044251A1 (en) * 1999-01-27 2000-08-03 Spenco Medical Corporation Therapeutic magnetic insoles
WO2000059423A1 (en) * 1999-04-01 2000-10-12 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
WO2000061117A1 (en) * 1999-04-08 2000-10-19 R.P. Scherer Corporation Fast-dispersing dosage forms containing fish gelatin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3253127B2 (en) * 1991-06-07 2002-02-04 帝國製薬株式会社 Preparation containing bioactive polypeptide
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
EP0517211A1 (en) * 1991-06-07 1992-12-09 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide containing pharmaceutical composition
US5298256A (en) * 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
WO2000044251A1 (en) * 1999-01-27 2000-08-03 Spenco Medical Corporation Therapeutic magnetic insoles
WO2000059423A1 (en) * 1999-04-01 2000-10-12 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
WO2000061117A1 (en) * 1999-04-08 2000-10-19 R.P. Scherer Corporation Fast-dispersing dosage forms containing fish gelatin

Also Published As

Publication number Publication date
NO335167B1 (en) 2014-10-06
JP2006502972A (en) 2006-01-26
AU2003233118B2 (en) 2006-10-26
WO2003094886A3 (en) 2004-07-22
CA2484724C (en) 2007-01-16
NZ535861A (en) 2006-11-30
DE60307082T2 (en) 2007-01-18
CA2484724A1 (en) 2003-11-20
AU2003233118B8 (en) 2009-07-30
HRP20041152A2 (en) 2005-04-30
AU2003233118A1 (en) 2003-11-11
NO20045345L (en) 2005-02-07
DE60307082D1 (en) 2006-09-07
PT1501534E (en) 2006-09-29
WO2003094886A2 (en) 2003-11-20
DE60307082T4 (en) 2015-04-30
BR0309819A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
HRP20041152B1 (en) Pharmaceutical formulations
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
CY1111821T1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING AN OBTAINABLE ANALYTIC
AP2004003055A0 (en) Platinum derivative pharmaceutical formulations.
HK1100166A1 (en) Effervescent oral opiate dosage form
PL356904A1 (en) Pharmaceutical compositions
DE60327103D1 (en) PHARMACEUTICAL FORMS CONTAIN A PROTON PUMP, A NAZID AND A BUFFER
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
MXPA03005340A (en) Novel medicament compositions based on anticholinesterase drugs and on ciclesonides.
DK0994710T4 (en) Pharmaceutical compositions for oral administration comprising a benzylhydrylpiperazine and a cyclodextrin
NO992102D0 (en) Peptide composition, as well as pharmaceutical composition and cancer vaccine including the peptide composition
NO20062605L (en) Pharmaceutical formulation containing flavoring substances with improved pharmaceutical properties
ITMI20011401A0 (en) PHARMACEUTICAL FORMULATIONS FOR THYROID HORMONES
DE60312049D1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHANT AGENT
IL173929A (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
ATE285753T1 (en) CHEWABLE TABLET CONTAINING LYSINE
SE0200657D0 (en) Novel Formulation
PT1355906E (en) 2H-1-BENZOPYRANE DERIVATIVES PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS
DK1273301T3 (en) Pharmaceuticals based on active ingredients that can be used for illicit administration
DK1268522T3 (en) LH-RH antagonists as well as their preparation and use thereof as drugs
MY141008A (en) Oral formulations of deoxypeganine and their uses
DK1011329T3 (en) 7-Methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
NL1023797A1 (en) Pharmaceutical dosage form that bears pregnancy-friendly decorations.
ZA200204905B (en) Improved pharmaceutical dental formulations.
HUP0204117A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190425

Year of fee payment: 17

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200424

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210427

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20220426

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20230507